Summary
40 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
What to watch
- Revenue fell by 61% a year over the last 3 years.
- The company made a loss over the last 12 months.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue fell by 39% a year over 5 years. Over the last 3 years it fell by 61% a year.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $56.6M.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Neutral- Buy 5
- Hold 9
- Sell 0
Today's price within the analysts' price targets
The average target of $17.02 is 94% above today's price. 36% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
The company reports no revenue by product.
By region
The company reports no revenue by region.